GAITHERSBURG, Md., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will ...
After hours: February 14 at 7:59:36 PM EST Loading Chart for ALT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback